Chelsea Manning Wins Fight to Be Called “She”

In a legal fight overs pronouns, chalk one up for gender rights. Chelsea Manning, the Wikileaks leaker formerly known as Bradley Manning, will now be referred to as “she” or a gender-neutr...
Chelsea Manning Wins Fight to Be Called “She”
Written by Josh Wolford

In a legal fight overs pronouns, chalk one up for gender rights.

Chelsea Manning, the Wikileaks leaker formerly known as Bradley Manning, will now be referred to as “she” or a gender-neutral pronoun in all future court proceedings.

“This is an important victory for Chelsea, who has been mistreated by the government for years,” said Manning’s attorney Nancy Hollander in a statement. “Though only a small step in a long legal fight, my co-counsel, Vincent Ward, Captain Dave Hammond, and I are thrilled that Chelsea will be respected as the woman she is in all legal filings.”

What this means, in effect, is that the US military must stop referring to Chelsea Manning as a man.

In September of last year Manning sued the US Department of Defense, claiming she had been “denied access to medically necessary treatment” in connection with a gender disorder.

“She brings this action to compel defendants to treat her serious medical needs consistent with their obligation under the Constitution,” said the lawsuit. Manning’s lawyers claimed that lack of hormonal treatment would cause Manning to “suffer continued pain, depression and anxiety” and that she “is at an extremely high risk of self-castration and suicidality.”

Manning accused the military of stalling.

But then last month, the DoD gave in.

“After carefully considering the recommendation that (hormone treatment) is medically appropriate and necessary, and weighing all associated safety and security risks presented, I approve adding (hormone treatment) to Inmate Manning’s treatment plan,” wrote Col. Erica Nelson in a memo.

Above: Army Image of Chelsea Manning, in 2012, when known as Bradley Manning

Get the WebProNews newsletter delivered to your inbox

Get the free daily newsletter read by decision makers

Subscribe
Advertise with Us

Ready to get started?

Get our media kit

Advertise with Us